Good morning, everybody, and welcome to the Materion's Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I would now turn the conference over to your host, Mr. John Zaranec, Chief Accounting Officer. John, over to you.

Good morning, and thank you for joining us on our fourth quarter 2022 earnings conference call. This is John Zaranec, Chief Accounting Officer. Before we begin our remarks this morning, I would like to point out that we have posted materials on the company's website that we will reference as part of today's review of the quarterly results. You can also access the materials through the download feature on the earnings call webcast link. With me today is Jugal Vijayvargiya, President and Chief Executive Officer; and Shelly Chadwick, Vice President and Chief Financial Officer. Our format for today's conference call is as follows: Jugal will provide opening comments on the quarter and the full year as well as an update on key strategic initiatives. Following Jugal, Shelly will review the detailed financial results for the quarter and the year in addition to discussing our expectations for 2023. We will then open the call for questions. Let me remind investors that any forward-looking statements made in this presentation, including those in the outlook section and during the question-and-answer portion, are based on current expectations. The company's actual performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors. Those factors are listed in the earnings press release we issued this morning. Additionally, comments regarding earnings before interest, taxes, depreciation, depletion and amortization, net income and earnings per share reflect the adjusted GAAP numbers shown in Attachments 4 through 7 in this morning's press release. The adjustments are made in the prior year period for comparative purposes and removed special items, noncash charges and certain discrete income tax adjustments. And now I'll turn over the call to Jugal for his comments.

Thanks, John, and welcome, everyone. It's great to be with you today and share details on another record quarter for Materion, which closes out a record year. This year, we marked several milestones for our company, crossing $1 billion in value-added sales, delivering over $300 million in quarterly sales, reaching nearly $200 million in EBITDA and crossing $5 for EPS. Our transformation into a global leader in high-performance Advanced Materials is delivering as we're driving a step change in both our sales and earnings. Our strong execution and delivery on strategic growth initiatives are enabling us to consistently outgrow our end markets. An expanding list of customers continue to place their trust in us for the development of next-generation solutions aligned with global mega trends. These strategic partnerships are helping to build a healthy pipeline for future growth and strengthening our position for 2023. We brought this year to a record close with an incredible 11th consecutive quarter of VA sales growth. The new facility for precision clad strip project contributed meaningfully as we fully qualify the facility. In addition, we continue to supply clad strip from our legacy plants. Our acquisition of HCS-Electronic Materials continued to outperform, delivering on robust demand from our customers. In total, the progress we've made on organic and inorganic initiatives drove record top and bottom line growth with EBITDA margins reaching 18% in the quarter, tracking well towards our midterm target of 20% and contributing to record quarterly earnings of $1.49 per share. For the full year, we delivered year-on-year increases of 30% or more across sales, EBITDA and EPS. It was an exceptional year in our company's transformation. Organic growth investments and strategic customer partnerships contribute more meaningfully to our results. The integration of HCS-Electronic Materials has gone extremely well as the power…

Thanks, Jugal, and good morning, everyone. During my comments, I will reference to the slides posted on our website this morning, starting on Slide 13. As Jugal outlined in his opening remarks, we achieved another record quarter of value-added sales, adjusted EBITDA and earnings per share in the fourth quarter. Value-added sales, which excludes the impact of pass through precious metal costs were $309.2 million for the quarter, up 30% from the prior year. This significant increase was driven by strong demand across the industrial, aerospace and energy markets, along with higher precision clad strip sales in the fourth quarter. Organic VA sales, excluding the impact of acquisitions and currency, increased approximately 26% compared to the prior year with significant above market growth. We delivered adjusted earnings of $1.49 per share in the fourth quarter, up 32% as compared to the prior year despite substantial interest headwind. Moving to Slide 14. Adjusted EBITDA in the quarter was $55.6 million or 18% of value added sales, up 40% from the prior year. The increase was largely driven by higher volume, favorable price/mix and positive contribution from our HCS-Electronic Materials acquisition. These strong growth drivers were partially offset by commercial and R&D investments as we continue to support our organic growth initiatives. Now let me review fourth quarter performance by business segment. Starting with our Performance Materials business on Slide 15. Value-added sales were a record $177.6 million, an increase of 53% compared to prior year. The increase was driven by strong performance in the industrial, energy and aerospace end markets and higher defense and hydroxide shipments. In addition, the new precision clad strip plant contributed near full run rate with additional shipments from our legacy facility. EBITDA, excluding special items, was a record at $44.3 million and a record 25% of…

Thank you. The floor is now open for questions. [Operator Instructions] Your first question is coming from Daniel Moore of CJS Securities. Daniel, your line is live.

Good morning, Jugal. Good morning, Shelly. Thanks for taking the questions.

Good morning.

Good morning, Dan.

Start with the two new partnerships that you announced this morning, maybe just a little bit more detail on the specific product applications for each and what the revenue opportunity and ramp could look like over the next one to two years?

Yeah. So great partnerships. The first one we announced is a funded one with about a $15 million investment that we indicated. That investment will be spent this year really putting capacity in place. We expect to have the sales completed, I would say, this year and really primarily next year in this project. Really, as I said, exciting partnership. I'm not able to go too much into detail, Dan, on what the product is or specific materials that we're going to supply just based on the confidential nature of the contract that we have. But it is quite exciting and it actually impacts a couple of our facilities that will put capacity increases in, and then be able to supply, as I said, between this year and next year with the majority of it, I would say, next year. With the second partnership, this is one that we actually have capacity today. So there's not really any funding required for the second item, which is the critical space application. We're going to utilize our existing capacity that we have. It is a three year agreement that we have reached with the customer. As you know, space is an important megatrend for us. We've talked about it about a year ago in one of our calls. And this is just a really exciting application in proposal systems. So our materials being utilized for that. We're going to start delivering yet, I would say, this year, in the second half of this year of that initial $10 million order and then into next year. And our expectation is that we'll continue to do that over that 3-year timeframe and then, of course, beyond that as well. Both of these opportunities are part of our Performance Materials segment. So quite excited about continued organic growth opportunities in our company.

Very helpful. Overall, it sounds like you're looking for kind of a positive, maybe low to mid-single-digit growth year for value-added sales, that -- hearing that correctly, putting all the pieces together, number one. Number two, what does the cadence look like? Are we likely to start off in that clip or maybe a little slower given some of the near term headwinds in semi?

Yeah. I mean let's just start with semi, because that is, as you know, sort of a question mark, I think, that many companies have right now, including us. I would say that, in general, it's probably a slower first half as inventory correction works and then better second half as the pickup is expected. Semi is about a third of our business, so that certainly has an impact on our overall company. And so, I would expect the first half to be a little bit slower than the second half in terms of sales. And I guess you could kind of extrapolate that to the earnings part of the company as well. We think when you look at our markets chart, which we have included in our deck, I think it's Slide 10. Majority of the markets that we participate in are -- we believe are going to be positive. So a little north of zero to three or a little bit more than three for a couple of them, which is aerospace and energy. Semi is the big one as we indicated, which is going to be perhaps a little bit more negative. So I think your assessment is probably reasonable in terms of the type of growth, maybe the company may experience overall. But I certainly would say that it is going to be a first half start a bit on the software side, but then really deliver much more in the second half. But overall, we're excited. I mean, because you're looking at an 8% growth on the EPS side. I mean the operational performance, we think, of the company is going to be somewhere in the 14-15 maybe type of a range. We have a little bit more interest, of course, that we have to deal with, so the EPS is around eight. But I think, overall, it's going to be a good year for us.

And Dan, maybe since you talked about timing, I would just talk about the sequential Q4 to Q1. We had a really strong Q4. As Jugal talked about, we'll see the semi softening in Q1. So we certainly expect to be up year-on-year, maybe 10% earnings from Q4 to Q1, but be a little bit potentially softer than Q4.

Very helpful, Shelly. Last for me, and I'll jump out. Cash flow picked up nicely in the quarter, obviously. And you gave the outlook for CapEx. Just talk about kind of what your expectations are for working capital and cash generation in fiscal 2023 and with the balance sheet now leverage down to that kind of midpoint of the range and declining any shifts in order of priority for capital allocation. Thanks.

Yeah. No, great question. And we were pleased with our cash flow generation in Q4. Certainly, we're keeping debt in view to make sure that our leverage is in the low to mid part of that range. I think is what we're targeting at this point given where we are kind of in the cycle of things. Our CapEx was a bit lower as we had some CapEx in accounts payable at year-end. So that means in Q1, we're going to have a bigger payment for CapEx than maybe normal. So I don't think we're going to see a real strong free cash flow number out of Q1, but expect a good number for the whole year. And we'll bring that debt down a bit more. I don't think we're going to put that as number one priority. As you saw, the CapEx number is still healthy. We've got a lot of growth opportunities. But you'll see that debt number come down. Right now, we're at 2.1. We'll certainly be in the high-one’s next time this year -- this time next year, sorry.

Perfect. Jump back with any follow-ups. Thank you.

Thank you very much. Your next question is coming from Phil Gibbs. Phil, your line is live. Phil, are you on mute?

Maybe we'll go to the next and come back to Phil.

Yes. Okay. Just one second. Just bear with me. I think there might be a technical issue with the panel, hang on a second. I'm really sorry.

Jenny, this is -- I'm helping out. Phil Gibbs will be our next question. Phil, your line is live. Please go ahead.

Can you hear me now?

Yes, Phil. I can hear you.

All right. Perfect. Good morning.

Always something, right?

Yeah.

First question is just on the defense and hydroxide piece that you mentioned. I know it's typically a good kicker to your mix, and we saw a lot of our other companies in the specialty metals arena have good quarters and defense partially maybe because of the war and international demand. So what was the pickup quarter-on-quarter for PAC, meaning how outsized was it? And then what should we expect to persist to some of these geopolitical and macro things persist?

Yeah. So Phil, we had mentioned, when you look at defense, I think when we -- in our Q3 call, we had mentioned that there may be some defense orders on timing that we have been waiting on and we've been trying to get them in that may benefit in Q4. And that's exactly what happened. And they benefited here in Q4. We expect defense to be a good market, just in terms of going into 2023. We've noted in our Slide 10 that it's probably somewhere in the zero to three type of a range, so from a mid-growth type of a market for us. But that certainly was a positive for us in Q4. And then hydroxide, I mean, as you know, that one we typically have one or two shipments per quarter, depending on the needs the customer may have. And we happen to have a shipment -- extra shipment in Q4 that benefited us. We would expect the shipment timing for 2023 to be relatively in line with, let's say, the historical rate that we've had. So I wouldn't expect anything unusually positive or negative from the hydroxide shipments.

And maybe just to add some color on Q4. As you know, Phil, the defense shipments can be kind of lumpy. They come in chunks versus the consistent throughout the year. So year-on-year in Q4, you saw a pretty significant growth in the 20s, if you would, percentage wise, which certainly helped with our mix.

Okay. That's helpful. And then as a second question, I know the tantalum misalignment impacted Q3, I think, to the tune of $4 million or $5 million, not really sure what it was in the fourth quarter. But I remember you expected some of those things to gradually get better. I don't think the first quarter was inclusive of that, but some better contracts and some things timing up a little bit better by the second quarter. Can you give some color in terms of where those things stand?

Yeah. Maybe I'll start on that one. So we talked about the $4 million in Q4. That looked better in Q3, closer to $3 million. We will see that still work out in Q1 as we're working through some higher cost inventory. The negotiations with the customers are largely behind us. So we're seeing some of that pricing start to feather in as we enter the year, but some contracts renegotiate in the year as well. So that's why we'll still see a little bit of a hangover as we start out 2023.

Is that still reasonable to suspect that, that's done by the second quarter for the most part?

Yeah. I think what we had indicated is for the most part, it would start to phase out in the second quarter. And then the second half, we expected it to be a little bit on the clean side. So that's the expectation.

Thanks so much.

Thank you. Your next question is coming from Dave Storms from Stonegate Capital Markets. Dave, your line is live. Please proceed.

Good morning. And thanks for taking my questions. Very strong year-over-year EBIT margin expansion in Performance Metals on a value add level. Can we expect any of that to be stickier? Or is that more just a product of maybe inflation moderating or more macro trends?

Well, our Performance Materials business certainly did really well in Q4. I mean, there's a number of factors. The business is continuing to drive organic growth as we move forward. Some of the operational challenges that we had in Q3, we got those challenges behind us. We just mentioned, for example, the positive mix with the defense and hydroxide. Both of those kind of tend to go a little bit more in the Performance Materials business. We also had the precision clad business ramp much more in Q4. So that certainly was a favorable item. So I would expect that as we move forward, some of these things are going to continue to benefit and then some, certainly, the onetime type of things like the defense and hydroxide are going to taper off. So we expect Performance Materials to continue to do well into 2023, but I'm not sure the run rate -- the rate that was delivered in Q4 is something that we can replicate four times this year.

Yeah. This -- it's not the new floor, right? So EBIT was at around 20% -- or 18%, sorry, for the year. And 20% to 21% in the quarter, I think we'll do better than the year, but 21% is certainly not the floor.

That's perfect. And just touching on the precision clad real quick. Shelly, I know you mentioned in your comments that, that was near full run rate. Just curious, is there any color as to what full run rate would look like?

So yeah, I would say we exited the year near full run rate, so probably not from the new facility at full run rate for the whole quarter. But we did have the benefit of also shipping from our legacy facilities. So in total, it was really favorable volume. We do expect to have all the volume coming out of the new facility in 2023, and we're getting very close to full ramp in that facility.

That's perfect. Thank you. One more, if I could. Just wondering, Shelly, you also mentioned order book looks really good. I was wondering if there was anything specific to China and the reopening over there. And if there's any [indiscernible] we can expect from the supply chain or anything of that nature.

Yeah. No, our order book continues to look strong. I mean the mix of our order book certainly is changing a little bit just based on the market conditions. So for example, we've talked about semiconductor and what that market is doing. So our order book on that one is a little bit stressed, but we have a really positive order book on some of the other markets. So I think, overall, our order book continues to be favorable and one that supports our guide that we've provided for 2023, which is a substantial growth from 2022 levels. China opening up, certainly, has a, I want to say, a positive impact, but our business in China is relatively small in comparison to our total company. So it has a small positive impact, but nothing of a meaningful impact.

That's perfect. Thank you very much.

Thank you. [Operator Instructions] And our next question is coming from David Silver from CL King. David, your line is live. Please go ahead.

Yeah. Hi. Good morning. Thank you.

Good morning, David. Yeah. So a couple of questions. I apologize, there'll probably be a little hopscotching around here. First thing I wanted to ask you about was the effect of currency on your operations this year. And also what are your assumptions for currency impacting -- well, what was the currency impact assumed in the fiscal year 2023 EPS guidance range? And if you could, I mean, is there a revenue -- a delta on the revenues, delta on the adjusted EPS. If you had that, that would be great. Thank you.

So one good thing about our business, where we have currency exposure, we've got pretty good matching on cost. So what we see on the revenue line is usually much bigger than what we would see on the EBITDA line. So we're well protected from that perspective. When we go into a new year, we're often looking at keeping it stable with where we ended the year. So we don't make big calls on what we think is going to happen with currency. What we saw this year was not overly meaningful, talking maybe $10 million or so for the top line, but nothing near that to the bottom line.

Okay. And then just maybe kind of more of a theoretical question or philosophical question. But a number of my industrial and electronic materials companies have talked about the significant impact of inventory destocking during the fourth quarter, both direct their sales but also indirect may be affecting their customers downstream. I may have missed it, I did not hear too much reference to that. And I'm just wondering, was destocking an issue? Do you think it will be an issue in the first half of 2023? Or is it the case that maybe the more Advanced Materials nature of your portfolio doesn't lend itself as readily to the kind of buffer stock buildup and drawdown that maybe has been characteristic of some of your end markets more broadly? Thank you.

Yeah. Well, I think the inventory correction issue or destocking that you mentioned is definitely an issue in the semiconductor space. Not only are we seeing it, but I think the entire market in the semi space is seeing that. We expect that to work its way out, I would say, in the first half and then pick back up in the second half. That's one of the reasons why we've got semiconductor as a market, perhaps a little bit less than zero from a year-over-year perspective. So I think that is an issue, David, and it is something that I think we're experiencing. And certainly, I'd say, pretty much the entire semi industry is experiencing. When I look at our other markets, I don't see destocking as an important element. I think other markets are continuing to move forward. I mean as we've highlighted in our chart, Chart 10 of kind of how we see 2023 coming along, we do see, in general, I would say, a little bit softer first half versus the second half, but a lot of that is due to the semiconductor side just because that business is about third of our business. So it is an issue for part of our business, but I would say not an issue for some other parts of our business.

Okay. Next couple of questions I think are going to be on the -- would be on the Electronic Materials business. And I'm going to quote just the sentence from the press release this morning. So you said the successful -- I'm going to paraphrase, but the successful integration of HCS and the power of their combined teams is quote unquote “generating value beyond our expectations”. So the generating value beyond our expectations is what I was wondering about. In particular, when I think about that in the context of some of the goals or some of the opportunities with combining HCS. I'm thinking more along the lines of maybe revenue synergies. In other words, cost synergies were probably expected and could be identified ahead of time to a certain extent, whereas revenue synergies, there's potential but the timing is always -- the timing and execution are always highly uncertain. But maybe if you could comment on what the -- beyond our expectations element of the HCS acquisition integration combination has -- how that has played out.

Yeah. Well, first of all, I think the HCS acquisition, just like our quota indicator, I mean it has delivered really well for us. Our teams combined with the HCS team have worked on so many different fronts to deliver. During the year, we were able to add over 20% headcount to the facility and increase our output from the facility. We announced over $20 million worth of capital investments that we're putting in place to be able to put new capacity for the business. The number of initiatives that our teams have been working on where they have worked together to go and offer our complete portfolio of Electronic Materials to the top-15 semiconductor manufacturers has been very powerful. So I think there's a number of things that have happened. Certainly, all of those things, by the way, have led to great financial results as well for that business, I would say, much better than what the synergies levels that we had indicated. I think the other thing that's been very interesting, and we've talked about this, is when you look at tantalum, and the application of tantalum continues to increase in general, right? The smaller the nodes are getting, the more application for tantalum. And so even though there's the short-term softness on the memory side, the logic side is continuing very strong, and we would expect the memory side to be recovering. So the long-term trend of this business is extremely good and extremely healthy. So I think it's a combination of things when we say beyond expectations, combination of how things have turned out on our top line with the synergies, combination of the investments that we've made, the people that we've actually put in place as well as, I think, the future opportunities that we have for our combined portfolio. So all of that put together, I think just is very, very favorable for us, and we're excited about this business.

Okay. I'd like to kind of follow up on the Electronic Materials outlook? And I apologize in advance, this question will be a little more disjointed than normal. But in the United States, there's a number of very large wafer fabs and related units being put -- coming on stream or underdevelopment now, due to come on stream between, let's say, early 2024 through 2026. And it's my opinion that the wafer fab development is moving maybe a little bit faster than what I would call the ecosystem, the suppliers and support and logistics and whatnot. And along those lines, two things. I was wondering if you could comment on -- generally, on how you see the opportunities for your products and services developing as those big new wafer fabs are completed and getting commissioned on ramp-up. And then secondly, how does the Chips Act or the new level of aid that's available for semiconductor manufacturer in this country, how does that play into your growth strategies or your ability to tap into that source of financial support, et cetera? So just the growth that had already been announced and now the financial support at the federal level. Thank you.

Yeah, yeah. Well, first of all, as we've already indicated, I think, on the call and we continue to indicate, this is a space that we're very excited about. The acquisition that we did, of course, is in the semiconductor space. We see this as long-term growth play for us. It's producing good short-term results, and we expect it to produce good long-term results. Our footprint, our R&D footprint and our manufacturing footprint is primarily in North America. And the acquisition that we made here about a year ago is also in North America. So I think we are very well positioned to continue to work with all the semiconductor manufacturers. As we indicated, we have access to all of the top-15 semiconductor manufacturers. And then we are able to have both R&D as well as manufacturing in region to support them. So we see that as a very positive for us on a go-forward basis. When you look at then what additional things we can do, I mean we certainly are involved in the Chips Act discussions. We're studying it very carefully. We're looking at what options there could be. We're looking at which of these capabilities and skill sets that we have that we could further strengthen. And so, we're involved in a number of discussions on how we can take advantage of and support the chip manufacturers as they grow their capacity. So as we have more on that to communicate, we certainly will. But yes, that is definitely one of the initiatives that we're engaged in.

Okay. And then just last question. And I apologize when Shelly was going through this part of her discussion. I was a tiny bit distracted, but just to touch base on the -- your third segment, the Optics. I think you were saying that -- you were indicating that maybe the restructuring, reshaping had kind of reached a point where the unit there has been stabilized and could be positioned for growth. And I believe you mentioned a healthy backlog, but would it be fair to say that we should look for kind of an inflection point or a turnaround to growth overall in that segment, full year 2023 versus full year 2022? Thank you.

Yeah. I think that's fair to say that. As we look at our 2023 and kind of look at the new business initiatives that the business is involved in, we would expect that those things to kick in during the year, certainly, the back half of the year then would have more of a benefit than the front half of the year. But on a full year basis, we would expect that business to have growth on a year-over-year basis on both the top and bottom line. So we're excited about that. I mean, it's been a great business for us. It's gone some -- gone through some headwinds here over the last 12 months or so, just based on customer decisions and some of the life sciences product discontinuation that happened. But in general, this is a great business for us, and we're looking forward to be able to share the turnaround here during the year.

Very helpful. Thank you very much.

Thanks, David.

Thank you. And there are no further questions in queue. I would now like to turn the floor over to John Zaranec for any closing remarks.

Thank you. This concludes our fourth quarter 2022 earnings call. A recorded playback of this call will be available on the company's website, materion.com. I'd like to thank you for participating on the call this morning and your interest in Materion. I will be available for any follow-up questions, my number is (216) 383-4010. Thanks again.

Thank you. This does conclude today's conference call. You may disconnect your phone lines at this time and have a wonderful day. Thank you for your participation.